CD8A and neoplasm: Additionally, it has been demonstrated in several tumor types that blocking this macrophage signaling using inhibitors or antibodies might prevent the recruitment of M2-like TAMs, increase the functionality of tumor-infiltrating CD8+ T cells, and promote the response to immunotherapy [196].